Literature DB >> 7934808

Internal involvement in localized scleroderma.

L Dehen1, J C Roujeau, A Cosnes, J Revuz.   

Abstract

We studied 76 consecutive patients with localized scleroderma (morphea with or without linear scleroderma) and analyzed the frequency, prognosis, and predictors of internal involvement in a subset of 53 patients systematically investigated for the presence of such involvement. Internal involvement was found by systematic examination in 16 patients. Only 2 of them, including 1 patient who developed systemic scleroderma, had symptomatic and severe visceral disease. The other 14 patients had asymptomatic and minor abnormalities consisting of abnormal lower sphincter pressure, and/or peristaltic failure in the esophagus and slightly impaired carbon monoxide diffusion in the lung. Frequent seroimmunologic abnormalities had no predictive value. Three parameters were found to be associated with internal involvement: male gender (p < 0.05), increasing number of plaque-like lesions (p = 0.02) and hypergamma-globulinemia at 1st examination (p < 0.005). Mild esophageal and pulmonary involvement are not rare in morphea but are usually silent. In our series, after a median follow-up of 48 months, such involvement did not impair the prognosis. The mildness of these visceral abnormalities suggests that they do not justify routine detection in asymptomatic patients. Morphea and systemic scleroderma behave as 2 different diseases.

Entities:  

Mesh:

Year:  1994        PMID: 7934808     DOI: 10.1097/00005792-199409000-00002

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  8 in total

Review 1.  Systemic manifestations in localized scleroderma.

Authors:  Francesco Zulian
Journal:  Curr Rheumatol Rep       Date:  2004-12       Impact factor: 4.592

2.  Autoimmune disease and subsequent risk of developing alimentary tract cancers among 4.5 million US male veterans.

Authors:  Annelie M Landgren; Ola Landgren; Gloria Gridley; Graça M Dores; Martha S Linet; Lindsay M Morton
Journal:  Cancer       Date:  2010-11-02       Impact factor: 6.860

3.  A case of localized scleroderma in a sculptor and his wife.

Authors:  Richard Bakst; Carrie Kovarik; Victoria P Werth
Journal:  J Clin Rheumatol       Date:  2009-12       Impact factor: 3.517

4.  Distinct autoimmune syndromes in morphea: a review of 245 adult and pediatric cases.

Authors:  Justin J Leitenberger; Rachael L Cayce; Robert W Haley; Beverley Adams-Huet; Paul R Bergstresser; Heidi T Jacobe
Journal:  Arch Dermatol       Date:  2009-05

Review 5.  Pediatric scleroderma: systemic or localized forms.

Authors:  Kathryn S Torok
Journal:  Pediatr Clin North Am       Date:  2012-04-06       Impact factor: 3.278

Review 6.  Localized scleroderma: clinical spectrum and therapeutic update.

Authors:  Mariana Figueiroa Careta; Ricardo Romiti
Journal:  An Bras Dermatol       Date:  2015 Jan-Feb       Impact factor: 1.896

7.  Quality of Life and Optimism in Patients with Morphea.

Authors:  Beata Szramka-Pawlak; Aleksandra Dańczak-Pazdrowska; Teresa Rzepa; Aleksandra Szewczyk; Anna Sadowska-Przytocka; Ryszard Zaba
Journal:  Appl Res Qual Life       Date:  2013-11-10

8.  From Localized Scleroderma to Systemic Sclerosis: Coexistence or Possible Evolution.

Authors:  Dilia Giuggioli; Michele Colaci; Emanuele Cocchiara; Amelia Spinella; Federica Lumetti; Clodovero Ferri
Journal:  Dermatol Res Pract       Date:  2018-01-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.